Valeant CEO to Tell Senate Jacking Up Heart Drug Prices Was a ‘Mistake’

Outgoing Valeant Pharmaceuticals Chief Executive Michael Pearson plans to tell a U.S. Senate panel on Wednesday that he regrets his decision to acquire and jack up the price of two life-saving heart drugs, saying it was all a “mistake.” The Senate committee is one of two U.S.

Full Article Here